Best 5-alpha Reductase Inhibitor for prostatic neoplasms
3 5-alpha Reductase Inhibitor drugs indicated for prostatic neoplasms, ranked by our independent rating. The current highest-rated is propecia. Compare them with all treatments for prostatic neoplasms or the full 5-alpha Reductase Inhibitor class. Not medical advice — always consult a professional.
Top 5-alpha reductase inhibitor for prostatic neoplasms: 1. Propecia · 2. Proscar · 3. Finasteride
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Propecia | 70/100 | Prescription | $2 | View → |
| 2 | Proscar | 70/100 | Prescription | $2 | View → |
| 3 | Finasteride |
Full ranking · 3 drugs
Frequently asked
- What is the best 5-alpha reductase inhibitor for prostatic neoplasms?
- By our independent rating, propecia currently ranks highest among 5-alpha Reductase Inhibitor drugs used for prostatic neoplasms. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which 5-alpha reductase inhibitor drugs treat prostatic neoplasms?
- pharmaranks lists 3 5-alpha Reductase Inhibitor products indicated for prostatic neoplasms, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.